Shanghai C&D Innostic Medical Technology (SHE:301584) plans to offer up to 63,193,277 shares in an initial public offering on the Shenzhen Stock Exchange.
The shares on offer will be equivalent to 15% of the entire shareholding of the medical supplies company.
Following the IPO, Innostic will have 421,288,509 shares.
CITIC Securities (HKG:6030, SHA:600030) is the sponsor and lead underwriter of the offering.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.